Skip to main content
Premium Trial:

Request an Annual Quote

Nebula Genomics Raises $4.3M, Partners With Veritas

NEW YORK (GenomeWeb) – Nebula Genomics has raised $4.3 million in seed financing from venture capital firms and has also partnered with Veritas Genetics, the company said on Wednesday. 

Nebula, which was founded last year by Harvard University researchers including George Church, aims to build a platform on which genomic data can be shared by harnessing blockchain technology.

The startup secured funding from Khosla Ventures, Arch Venture Partners, Fenbushi Capital, Mayfield, F-Prime Capital Partners, Great Point Ventures, Windham Venture Partners, Hemi Ventures, Mirae Asset, Hikma Ventures, and Heartbeat Labs, and plans to use the financing to continue building a decentralized marketplace for genomic data.

Under the partnership with Veritas, Nebula will have access to Veritas' open-source software platform, Arvados.

"Our investors, along with Veritas, share our commitment to lowering access barriers to genomic data, and solving one of the primary roadblocks preventing personalized medicine becoming a reality today," Kamal Obbad, CEO and co-founder of Nebula Genomics, said in a statement. 

The Scan

Taking Stock of the Stockpile

The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.

Vitamin D From Tomatoes

According to Reuters, researchers in the UK have gene-edited tomatoes so their fruit contains vitamin D.

Cause Not Yet Spotted

NPR reports that a new study was unable to find a cause for persistent long COVID symptoms.

PNAS Papers on Central African Hunter-Gatherers, Myopia Development, Ancient Microtia Allele

In PNAS this week: population patterns among Central African hunter gatherers, effect of myopia-linked gene variant, and more.